AbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage ...

In the past dozen years, doctors have tried no fewer than 50 promising drugs and other treatments for multiple sclerosis. In no case has the promise been fulfilled. “MS” remains an inexorable ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type 1 diabetes, hepatitis ...

More than 90% of RRMS patients given vidofludimus calcium in a clinical trial were free of confirmed disability worsening ...

According to a 2022 study, the estimated total economic burden of multiple sclerosis in the U.S. was $85.4 billion in 2019, with a direct medical cost of $63.3 billion; indirect and nonmedical ...

An illustration of damaged nerve cells caused by multiple sclerosis. In this image, the nerve cells are blue, and immune system cells are orange. ... Let’s start with a little immunology 101.

EBV infection has long been associated with multiple sclerosis, but how the infection might contribute to multiple sclerosis has not been clear. More than 95% of people have been infected with this ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

Uveitis is uncommon in patients with multiple sclerosis (MS), but the link between the two entities is clearly established. While a common etiology or pathologic process remains unknown, shared ...

No matter how mild or severe your symptoms are, multiple sclerosis self-care options can make a difference. Create a ‘feel good’ toolkit MS is a persistent condition, even if some symptoms ...

How Bronze Age herders are linked to MS One of the key findings from the first batch of research, based on more than 1,600 genomes in the database, was connected to multiple sclerosis, often ...